View all cases
UPC APP 29243/2025
EP2401365 · REENGINEERING MRNA PRIMARY STRUCTURE FOR ENHANCED PROTEIN PRODUCTION
- Case details
- Status—ActionProcedural applicationCategoryConfidentiality (RoP 262A / 262.2)
- Parties
- Respondents
- BioNTech SEOperating co.
- BioNTech Manufacturing GmbHOperating co.
- BioNTech Manufacturing Marburg GmbHOperating co.
- BioNTech Innovative Manufacturing Services GmbHOperating co.
- BioNTech Europe GmbHOperating co.
- Pfizer Manufacturing Belgium NVOperating co.
- Pfizer SASOperating co.
- Pfizer ABOperating co.
- Pfizer Inc.Operating co.
Representatives- Christine Kanz-Hoyng Rokh Monegier
- Tobias J. Hessel-Clifford Chance Partnerschaft mbB
- Division
- Munich LD
- Judges
- Technology
- ChemistryBiotechnology
- Language
- —
- First decided
- Jul 15, 2025
How this compares
How long the court takes to reach a first decision.
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Munich LD | Locked |
| Judge András Kupecz | Locked |
At the UPC: Promosome LLC (15 cases)·BioNTech Group (21 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 14 other proceedings
UPC CoA 146/2026·UPC CoA 147/2026·UPC CoA 148/2026·UPC CFI 2819/2026·UPC CFI 2821/2026 and 9 more
Decisions
- 2025-07-15Application RoP262APublic
Summary: The Munich Local Division issued a procedural order on BioNTech/Pfizer's R. 262A RoP application to extend confidentiality protection to certain information in the Promosome LLC v. BioNTech/Pfizer infringement proceedings concerning EP 2 401 365. The court largely denied the extension, finding that the information was already covered by an existing confidentiality order of 10 March 2025.
Show the legal issues (3)
- Extension of confidentiality protection (R. 262A RoP)
- Existing confidentiality order coverage
- Access restrictions in infringement proceedings
Documents
- 6BE74F1C08BB75D0B760FB1F30966A40_en.pdf2025-07-15EN